VulnerabilityAwaiting Analysis

CVE-2026-15415

Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled…

MEDIUM 6.8EPSS 0.35%

Does this matter?

Lower severity and a low EPSS score (0.35%). Track it; it rarely justifies an emergency change on its own.

Description

AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.

CVSS 4.0: 6.8 MEDIUMCVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
EPSS: 0.35% probability · 29th percentile
CISA KEV: Not listed
Weakness: CWE-23
Source: ff89ba41-3aa1-4d27-914a-91399e9639e5

References

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.